07:00 , Aug 3, 2009 |  BC Week In Review  |  Clinical News

Ratioepo regulatory update

EMEA's CHMP issued a positive opinion on an MAA from ratiopharm for Ratioepo recombinant epoetin theta to treat symptomatic anemia in adults with chronic renal failure or non-myeloid malignancies receiving chemotherapy. ratiopharm GmbH , Ulm,...